Albemarle Corporation (NYSE:ALB) is a global leader in the production of specialty chemicals, with a strong focus on lithium, bromine, and refining catalysts. The company is a key player in the energy storage market, particularly in lithium production, which is crucial for electric vehicle batteries. Albemarle's competitors include companies like SQM and Livent Corporation, which also operate in the lithium sector.
On February 11, 2026, Albemarle is set to release its quarterly earnings. Analysts predict an earnings per share (EPS) loss of $0.40, with revenue expected to be around $1.35 billion. This revenue projection represents a 9.6% increase from the previous year, driven by growth in the Energy Storage segment, as highlighted by the company's effective cost management and improved lithium pricing.
The anticipated EPS loss for the quarter ending December 2025 marks a 54.1% improvement from the same period last year. Historical data indicates that changes in earnings estimates often correlate with short-term stock price movements.
Albemarle's stock has seen a remarkable 113.5% increase over the past year, outperforming the Zacks Chemicals Diversified industry, which declined by 17.4%. The company has consistently exceeded earnings expectations in three of the last four quarters, with an average earnings surprise of 35.3%. In the most recent quarter, Albemarle delivered an impressive earnings surprise of 79.4%.
The company's strategic cost and productivity initiatives, along with a recovery in lithium prices, have bolstered its performance. Albemarle's financial metrics, such as a price-to-sales ratio of 3.94 and a debt-to-equity ratio of 0.38, reflect its valuation and financial health. However, the negative price-to-earnings ratio indicates ongoing financial challenges. The upcoming earnings report will be crucial in determining the stock's near-term movement.
